Fresenius Medical Care AG (ETR:FME)
Germany · Delayed Price · Currency is EUR 39.55
-0.13 (-0.33%)
Oct 2, 2026, 5:38 PM CET
Fresenius Medical Care AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,516 | 11,384 | 12,957 | 11,138 | 8,970 | 16,742 | |
Market Cap Growth | -18.76% | -12.14% | 16.33% | 24.17% | -46.42% | -16.18% |
Enterprise Value | 21,408 | 21,569 | 23,982 | 23,987 | 23,326 | 29,623 |
Last Close Price | 39.68 | 39.19 | 41.30 | 34.49 | 27.07 | 49.39 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.86 | 11.64 | 24.09 | 22.32 | 13.32 | 17.27 |
Forward PE | 9.55 | 14.08 | 13.45 | 13.74 | 10.92 | 14.72 |
PS Ratio | 0.54 | 0.58 | 0.67 | 0.57 | 0.46 | 0.95 |
PB Ratio | 0.78 | 0.80 | 0.82 | 0.75 | 0.58 | 1.20 |
P/FCF Ratio | 5.89 | 6.45 | 7.68 | 5.73 | 6.21 | 10.24 |
P/OCF Ratio | 3.72 | 4.25 | 5.43 | 4.24 | 4.14 | 6.73 |
PEG Ratio | 2.77 | 1.25 | 0.86 | 1.16 | 3.94 | 1.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.10 | 1.10 | 1.24 | 1.23 | 1.20 | 1.68 |
EV/EBITDA Ratio | 6.21 | 8.23 | 10.22 | 9.85 | 9.29 | 10.59 |
EV/EBIT Ratio | 10.29 | 11.54 | 15.58 | 15.74 | 15.17 | 15.56 |
EV/FCF Ratio | 11.99 | 12.22 | 14.22 | 12.34 | 16.16 | 18.12 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.81 | 0.76 | 0.70 | 0.82 | 0.86 | 0.95 |
Debt / EBITDA Ratio | 3.27 | 3.31 | 3.64 | 3.85 | 4.06 | 3.82 |
Debt / FCF Ratio | 6.15 | 6.12 | 6.52 | 6.21 | 9.15 | 8.15 |
Net Debt / Equity Ratio | 0.73 | 0.64 | 0.61 | 0.71 | 0.76 | 0.84 |
Net Debt / EBITDA Ratio | 3.64 | 3.46 | 4.12 | 4.32 | 4.68 | 4.17 |
Net Debt / FCF Ratio | 5.56 | 5.14 | 5.73 | 5.41 | 8.14 | 7.14 |
Asset Turnover | 0.62 | 0.61 | 0.57 | 0.56 | 0.55 | 0.53 |
Inventory Turnover | 6.61 | 6.94 | 6.87 | 6.49 | 6.69 | 6.53 |
Quick Ratio | 0.63 | 0.85 | 0.92 | 0.91 | 0.85 | 0.76 |
Current Ratio | 1.07 | 1.26 | 1.40 | 1.42 | 1.27 | 1.10 |
Return on Equity (ROE) | 8.52% | 7.93% | 4.84% | 4.84% | 6.08% | 9.27% |
Return on Assets (ROA) | 3.98% | 3.62% | 2.85% | 2.73% | 2.74% | 3.60% |
Return on Invested Capital (ROIC) | 6.64% | 6.04% | 4.25% | 4.11% | 4.27% | 6.01% |
Return on Capital Employed (ROCE) | 8.30% | 7.60% | 5.50% | 5.50% | 5.30% | 7.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.92% | 8.59% | 4.15% | 4.48% | 7.51% | 5.79% |
FCF Yield | 16.97% | 15.51% | 13.02% | 17.46% | 16.09% | 9.77% |
Dividend Yield | 3.77% | 3.80% | 3.49% | 3.45% | 4.14% | 2.73% |
Payout Ratio | 42.67% | 43.19% | 64.91% | 65.86% | 58.74% | 40.49% |
Buyback Yield / Dilution | 4.44% | 0.76% | - | -0.06% | -0.06% | 0.41% |
Total Shareholder Return | 8.22% | 4.56% | 3.49% | 3.39% | 4.08% | 3.15% |